WAVE LIFE SCIENCES LTD. Other Comprehensive Income (Loss), Net of Tax
WAVE LIFE SCIENCES LTD. (WVE) reported Other Comprehensive Income (Loss), Net of Tax of $82.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-30
- WAVE LIFE SCIENCES LTD. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was $82.00K, a 90.70% increase year-over-year.
- WAVE LIFE SCIENCES LTD. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$4.00K, a 106.90% decline year-over-year.
- WAVE LIFE SCIENCES LTD. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was -$29.00K, a 124.17% decline year-over-year.
- WAVE LIFE SCIENCES LTD. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was $43.00K.
- WAVE LIFE SCIENCES LTD. other comprehensive income (loss), net of tax for fiscal 2025 was $12.00K.
- WAVE LIFE SCIENCES LTD. other comprehensive income (loss), net of tax for fiscal 2024 was -$138.00K.
- WAVE LIFE SCIENCES LTD. other comprehensive income (loss), net of tax for fiscal 2023 was -$95.00K.
- WAVE LIFE SCIENCES LTD. other comprehensive income (loss), net of tax for fiscal 2022 was -$210.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $82.00K 10-Q · filed 2026-07-30 | $78.00K derived: sum of 2 quarters · filed 2026-07-30 | ||
| 2026-03-31 | -$4.00K 10-Q · filed 2026-07-30 | |||
| 2025-12-31 | $12.00K 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$29.00K 10-Q · filed 2025-11-10 | $14.00K derived: sum of 2 quarters · filed 2026-07-30 | $72.00K derived: sum of 3 quarters · filed 2026-07-30 | |
| 2025-06-30 | $43.00K 10-Q · filed 2026-07-30 | $101.00K derived: sum of 2 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $58.00K 10-Q · filed 2026-07-30 | |||
| 2024-12-31 | -$138.00K 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $120.00K 10-Q · filed 2025-11-10 | $39.00K derived: sum of 2 quarters · filed 2025-11-10 | -$35.00K derived: sum of 3 quarters · filed 2025-11-10 | |
| 2024-06-30 | -$81.00K 10-Q · filed 2025-11-10 | -$155.00K derived: sum of 2 quarters · filed 2025-11-10 | ||
| 2024-03-31 | -$74.00K 10-Q · filed 2025-11-10 | |||
| 2023-12-31 | -$95.00K 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$32.00K 10-Q · filed 2024-11-12 | -$132.00K derived: sum of 2 quarters · filed 2024-11-12 | -$153.00K derived: sum of 3 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$100.00K 10-Q · filed 2024-11-12 | -$121.00K derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2023-03-31 | -$21.00K 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | -$210.00K 10-K · filed 2025-03-04 | |||
| 2022-09-30 | -$76.00K 10-Q · filed 2023-11-09 | -$218.00K derived: sum of 2 quarters · filed 2023-11-09 | -$304.00K derived: sum of 3 quarters · filed 2023-11-09 | |
| 2022-06-30 | -$142.00K 10-Q · filed 2023-11-09 | -$228.00K derived: sum of 2 quarters · filed 2023-11-09 | ||
| 2022-03-31 | -$86.00K 10-Q · filed 2023-11-09 | |||
| 2021-12-31 | -$208.00K 10-K · filed 2023-03-23 | |||
| 2021-09-30 | -$11.00K 10-Q · filed 2022-11-10 | |||
| 2021-03-31 | -$120.00K 10-Q · filed 2022-11-10 | |||
| 2020-12-31 | $122.00K 10-K · filed 2022-03-03 | |||
| 2020-09-30 | $23.00K 10-Q · filed 2021-11-10 | $28.00K derived: sum of 2 quarters · filed 2021-11-10 | $34.00K derived: sum of 3 quarters · filed 2021-11-10 | |
| 2020-06-30 | $5.00K 10-Q · filed 2021-11-10 | $11.00K derived: sum of 2 quarters · filed 2021-11-10 | ||
| 2020-03-31 | $6.00K 10-Q · filed 2021-11-10 | |||
| 2019-12-31 | $114.00K 10-K · filed 2021-03-04 | |||
| 2019-09-30 | $2.00K 10-Q · filed 2020-11-09 | $32.00K derived: sum of 2 quarters · filed 2020-11-09 | $129.00K derived: sum of 3 quarters · filed 2020-11-09 | |
| 2019-06-30 | $30.00K 10-Q · filed 2020-11-09 | $127.00K derived: sum of 2 quarters · filed 2020-11-09 | ||
| 2019-03-31 | $97.00K 10-Q · filed 2020-11-09 | |||
| 2018-12-31 | $37.00K 10-K · filed 2020-03-02 | |||
| 2018-09-30 | -$20.00K 10-Q · filed 2019-11-05 | $16.00K derived: sum of 2 quarters · filed 2019-11-05 | $65.00K derived: sum of 3 quarters · filed 2019-11-05 | |
| 2018-06-30 | $36.00K 10-Q · filed 2019-11-05 | $85.00K derived: sum of 2 quarters · filed 2019-11-05 | ||
| 2018-03-31 | $49.00K 10-Q · filed 2019-11-05 | |||
| 2017-12-31 | $407.00K 10-K · filed 2020-03-02 | |||
| 2016-12-31 | -$332.00K 10-K · filed 2019-03-01 | |||
| 2015-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$15.00K 10-K · filed 2018-03-12 | ||
| 2015-09-30 | -$13.00K 10-Q · filed 2015-12-17 | |||
| 2014-12-31 | -$169.00K 10-K · filed 2017-03-16 | |||
| 2013-12-31 | $135.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |